Jessica Surma
Family · Michigan City, INNPI 1245071646
Payments from drug & device makers
Across 205 payments — averaging $34.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$2K
- AbbVie$760
- Medtronic$727
- Neurocrine Biosciences, Inc.$360
- Novartis$285
- Vanda Pharmaceuticals Inc.$229
- plus $2K from 32 others
What the payments were for
- Travel & lodging$2,22032%
- Food & beverage$4,58766%
- Education$1763%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 8 | $2,176 |
| AbbVie | 57 | $760 |
| Medtronic | 6 | $727 |
| Neurocrine Biosciences, Inc. | 15 | $360 |
| Novartis | 13 | $285 |
| Vanda Pharmaceuticals Inc. | 6 | $229 |
| Teva Pharmaceuticals USA, Inc. | 4 | $207 |
| Argenx US, Inc. | 9 | $194 |
| TG Therapeutics, Inc. | 7 | $186 |
| Eisai Inc. | 3 | $174 |
| Lilly USA, LLC | 6 | $144 |
| SK Life Science, Inc. | 5 | $126 |
| Biogen | 6 | $125 |
| UCB, Inc. | 4 | $109 |
| Lundbeck LLC | 5 | $109 |
| Mallinckrodt Hospital Products Inc. | 4 | $105 |
| Neurelis, Inc. | 4 | $101 |
| AstraZeneca | 5 | $91 |
| Amneal Pharmaceuticals LLC | 4 | $91 |
| Pfizer | 4 | $77 |
| EMD Serono, Inc. | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Aucta Pharmaceuticals, Inc. | 2 | $48 |
| Novo Nordisk | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Acadia Pharmaceuticals Inc | 2 | $40 |
| Catalyst Pharmaceuticals, Inc. | 2 | $38 |
| Scpharmaceuticals Inc. | 1 | $29 |
| Cycle Pharmaceuticals Inc | 1 | $26 |
| Impel Pharmaceuticals LLC | 1 | $24 |
| Genentech USA, Inc. | 1 | $23 |
| Abbott | 1 | $22 |
| Viatris Specialty LLC | 1 | $20 |
| Exact Sciences | 1 | $18 |
| Bayer | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| GSK | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$2,065
- MINIMED 780G$669
- Leqembi$125
How this compares
$6,983 in reported general payments places this provider in the 95th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nortriptyline Hcl | 11 | $167 |
| Donepezil Hcl | 13 | $21 |
Paid to pharmacies, not to this prescriber.
Other family in Michigan City
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.